Bill · H.R. 5032· House(119-HR-5032)
Nitazene Control Act
- Introduced
- 8/22/2025
- Last activity
- 8/22/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Eugene Vindman
- Cosponsors
- - 1 - 3
- Introduced
- In Committee
What this bill would do
The Nitazene Control Act aims to amend the Controlled Substances Act to permanently schedule nitazenes as Schedule I substances. Nitazenes are a class of benzimidazole-opioids known for extreme potency and presence in the illicit drug supply. This bill seeks to preemptively address the spread of new analogs and streamline enforcement to protect public health. By implementing a class-wide permanent scheduling, the act moves substances that were temporarily scheduled into a permanent status. Additionally, the bill includes specific provisions regarding rulemaking authority and exemptions for ongoing research.
Yes· 3 of 4
Does this do more about addiction and overdose deaths?+7
The act addresses the proliferation of dangerous nitazene analogs to protect public health and reduce overdose deaths.
Does this put more money into scientific research?+2
The bill directs the Attorney General to expedite registration applications to ensure the continuity of research involving these substances.
Would students be better off under this?+1
The bill includes provisions to expedite the registration process for researchers to maintain continuity in scientific study.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Public Health Protection: The bill aims to protect public health by addressing the proliferation of new nitazene analogs that contribute to overdoses and fatal poisonings (Section 2).
-
Streamlined Enforcement: Class-wide permanent scheduling is intended to streamline enforcement efforts regarding these substances (Section 2).
-
Continuity of Research: Researchers conducting active research can maintain their work without immediately needing new registration, provided they meet certain criteria like having an active IND application or IRB approval (Section 3(d)(1)).
-
Support for Scientific Study: The Attorney General is directed to expedite registration applications for researchers to ensure their work can continue (Section 3(d)(2)).
Potential Negative Impacts for People
- Increased Regulatory Burdens for Researchers: While an exemption exists, researchers must still notify the Attorney General within 90 days and eventually apply for a formal registration to continue their work (Section 3(d)(1) and (2)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+7
- Education And Technology
- Increases Scientific Research Funding+2
- Demographic And Interest Groups
- Good For Students+1
- Governance And Ideology
- Improves Government Transparency+1
- 6/30/2026
- 1 Cosponsor added.
- 2/20/2026
- 1 Cosponsor added.
- 12/15/2025
- 1 Cosponsor added.
- 8/22/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
Michael BaumgartnerRepublican · Washington
Ryan MackenzieRepublican · Pennsylvania
Joe NeguseDemocrat · Colorado
Robert OnderRepublican · Missouri